APA (7th ed.) Citation

W, Y., L, W., Y, W., T, N., R, F., Y, Z., . . . J, L. (2026). Treatment patterns, effectiveness, and safety of daratumumab-based regimens in Chinese patients with multiple myeloma: Longer follow-up of the real-world MMY4032 study. Annals of hematology, 105(5), . https://doi.org/10.1007/s00277-026-06972-8

Chicago Style (17th ed.) Citation

W, Yang, et al. "Treatment Patterns, Effectiveness, and Safety of Daratumumab-based Regimens in Chinese Patients with Multiple Myeloma: Longer Follow-up of the Real-world MMY4032 Study." Annals of Hematology 105, no. 5 (2026). https://doi.org/10.1007/s00277-026-06972-8.

MLA (9th ed.) Citation

W, Yang, et al. "Treatment Patterns, Effectiveness, and Safety of Daratumumab-based Regimens in Chinese Patients with Multiple Myeloma: Longer Follow-up of the Real-world MMY4032 Study." Annals of Hematology, vol. 105, no. 5, 2026, https://doi.org/10.1007/s00277-026-06972-8.